爱尔眼科
(300015)
| 流通市值：954.92亿 | | | 总市值：1126.87亿 |
| 流通股本：79.05亿 | | | 总股本：93.28亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 16,047,172,893.34 | 10,251,764,472.11 | 5,020,539,960.94 | 16,109,946,687.31 |
| 营业收入 | 16,047,172,893.34 | 10,251,764,472.11 | 5,020,539,960.94 | 16,109,946,687.31 |
| 二、营业总成本 | 11,753,905,506.99 | 7,733,935,528.09 | 3,896,380,425.67 | 12,152,478,396.38 |
| 营业成本 | 7,713,247,573.26 | 5,180,996,744.06 | 2,636,233,113.96 | 7,980,388,803.34 |
| 税金及附加 | 39,227,855.04 | 23,952,573.48 | 9,667,229.37 | 44,619,556.99 |
| 销售费用 | 1,607,024,164.31 | 1,047,851,890.81 | 469,293,701.01 | 1,555,631,110.57 |
| 管理费用 | 2,084,378,870.07 | 1,326,486,556.85 | 665,556,532.07 | 2,293,464,647.01 |
| 研发费用 | 246,027,228.73 | 147,751,536.94 | 66,549,935.52 | 271,719,403.9 |
| 财务费用 | 63,999,815.58 | 6,896,225.95 | 49,079,913.74 | 6,654,874.57 |
| 其中:利息费用 | 145,571,853.71 | 96,846,851.03 | 48,502,641.46 | 177,647,497.63 |
| 其中:利息收入 | 86,811,466.87 | 52,777,263.14 | 24,403,006.14 | 87,649,549.23 |
| 加:公允价值变动收益 | -1,833,232.89 | 11,306,586.39 | 35,113,417.63 | -356,890,132.91 |
| 加:投资收益 | 28,040,314.07 | 19,725,504.37 | 3,399,520.17 | 43,909,887.92 |
| 资产处置收益 | 1,030,793.29 | -47,667.11 | 214,554.56 | -1,251,917.6 |
| 资产减值损失(新) | -692,464.57 | -675,395.96 | - | -95,463,836.19 |
| 信用减值损失(新) | -66,279,012.57 | -43,351,027.37 | -20,560,890.23 | -69,830,935.19 |
| 其他收益 | 189,105,228.62 | 17,568,808.03 | 11,184,692.01 | 56,558,167.27 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 4,442,639,012.3 | 2,522,355,752.37 | 1,153,510,829.41 | 3,534,499,524.23 |
| 加:营业外收入 | 7,109,804.97 | 4,165,651.71 | 2,117,065.74 | 12,330,115.58 |
| 减:营业外支出 | 150,862,725.35 | 110,140,257.4 | 22,647,889 | 211,774,085.46 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 4,298,886,091.92 | 2,416,381,146.68 | 1,132,980,006.15 | 3,335,055,554.35 |
| 减:所得税费用 | 778,412,448.06 | 481,395,353.04 | 232,275,114.5 | 646,059,017.62 |
| 六、净利润 | 3,520,473,643.86 | 1,934,985,793.64 | 900,704,891.65 | 2,688,996,536.73 |
| 持续经营净利润 | 3,520,473,643.86 | 1,934,985,793.64 | 900,704,891.65 | 2,688,996,536.73 |
| 归属于母公司股东的净利润 | 3,181,255,516.74 | 1,712,374,307.79 | 781,064,898.92 | 2,524,230,840.5 |
| 少数股东损益 | 339,218,127.12 | 222,611,485.85 | 119,639,992.73 | 164,765,696.23 |
| (一)基本每股收益 | 0.35 | 0.18 | 0.11 | 0.36 |
| (二)稀释每股收益 | 0.34 | 0.18 | 0.11 | 0.36 |
| 八、其他综合收益 | 2,483,208.92 | 48,097,546.15 | 14,330,809.88 | 4,424,804.2 |
| 归属于母公司股东的其他综合收益 | 6,852,724.78 | 53,096,967.25 | 14,330,809.88 | 10,266,960.32 |
| 九、综合收益总额 | 3,522,956,852.78 | 1,983,083,339.79 | 915,035,701.53 | 2,693,421,340.93 |
| 归属于母公司股东的综合收益总额 | 3,188,108,241.52 | 1,765,471,275.04 | 795,395,708.8 | 2,534,497,800.82 |
| 归属于少数股东的综合收益总额 | 334,848,611.26 | 217,612,064.75 | 119,639,992.73 | 158,923,540.11 |
| 公告日期 | 2023-10-26 | 2023-08-25 | 2023-04-26 | 2023-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |